1. DePuy ASR Hip Recall Revision Surgery
http://depuyhiprecallsite.com/
DePuyOrthopaedics wasfounded1895. It was the firstcommercial orthopaedicscompanyin the U.S.
that pioneeringspirit.Theirlong-standingcommitmenttoinnovationinpatientcare hashelped them
become a global leaderinorthopaedicdevicesandsupplies,includinghip,knee,extremity,trauma,
cement,andoperatingroomproducts.
Earlierthisyear,ithas beenreportedthatDePuyhasstartedpullingouttheirdefective products.The
companyhad stoppedsellingthe systeminlate 2009. On the 26th
of August2010, theyofficially
announcedthe recall of theirmalfunctioninghipreplacementsystems.
The DePuyhiprecall wasof the ASR hipimplant.Itcomesafterthe device wasmarketedforaboutsix
yearsbetween2003 and 2009. The defective hipsystemhasbeenimplantedinatotal of about 93, 000
patients. Thishiprecall affectstwoproductsbyDePuy namely,the ASRHipResurfacingSystemandthe
ASR XL AcetabularSystem.This DePuyhiprecall comesafteryearsof publishedreports,studiesanddata
indicatingthatthe device wasdefective andfailing inpatients. The reasonforthis DePuyhiprecall is
because of the alarmingnumberof complaintsandhighrevisionsurgeryrate forthe device.DePuy
statisticsshowthat“approximately12%of patientswhohadreceivedthe ASRresurfacingdevice and
13% of patientswhohadreceivedthe ASRtotal hipreplacementneededtohave arevisionsurgery.”
Afterthiscliff-hanger,DePuy Orthopedicsissued forahiprecall revision. Thismeansthat affected
patientswill undergoapainful andunnecessary DePuyhiprecall revisionsurgery. Of course,this
problemshouldhave beenfixedwiththe initial surgeryif notfor the defective DePuyhip.
In addition, DePuyrecommendsyearlymonitoring"toensure the ASRhipreplacementisfunctioning
well,eveninthe absence of symptoms."

2. However,DePuystatedinthe releasethatfew of these devicesremainonthe worldwidemarketdue to
itsdecisionlastyearto discontinuethe ASRsystemasa resultof decliningdemandandotherfactors.
Presidentof DePuyOrthopaedicsInc. alsostatedinthe release thattheyare committed toassisting
patientsandhealth care providersbyprovidinginformationthroughmultiplechannelsandpayingfor
the cost of doctorvisits,testsandproceduresassociatedwiththe hiprecall revision.